Publications

Journal Article
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 165 citations
Electronic publication date
February 28, 2001

View on Pubmed.gov 11024143 | View on doi.org 10.1128/jvi.74....

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Search for publications in this journal J Virol - 74(21):10142-52

Abstract

The binding of the viral major glycoprotein BLLF1 (gp350/220) to the CD21 cellular receptor is thought to play an essential role during infection of B lymphocytes by the Epstein-Barr virus (EBV). However, since CD21-negative cells have been reported to be infectible with EBV, additional interactions between viral and cellular molecules seem to be probable. Based on a recombinant genomic EBV plasmid, we deleted the gene that encodes the viral glycoprotein BLLF1. We tested the ability of the viral mutant to infect different lymphoid and epithelial cell lines. Primary human B cells, lymphoid cell lines, and nearly all of the epithelial cell lines that are susceptible to wild-type EBV infection could also be successfully infected with the viral mutant in vitro, although the efficiency of infection with BLLF1-negative virus was clearly lower than the one observed with wild-type EBV. Our studies show that the interaction between BLLF1 and CD21 is not absolutely required for the infection of lymphocytes and epithelial cells, indicating that viral molecules other than BLLF1 can mediate the binding of EBV to its target cells. In this context, our results further suggest the hypothesis that additional cellular molecules, apart from CD21, allow virus entry into these cells.

References

J Virol. 1998 Jul;72(7):6119-30

Science. 1998 Jun 5;280(5369):1618-20

J Immunol. 1998 Nov 1;161(9):4604-10

J Virol. 1999 Mar;73(3):2115-25

Cited by 165 citations (total)

Journal Article

Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles.

Electronic publication date April 11, 2008

Search for publications in this journal J Virol

Marisa Granato [...] Henri-Jacques Delecluse et al.

Previous genetic and biochemical studies performed with several members of the Alphaherpesvirus subfamily have shown that the UL31 and UL34...

Journal Article Research Support, N.I.H., Extramural

Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells.

Electronic publication date October 25, 2006

Search for publications in this journal J Virol

Susan M Turk [...] Lindsey M Hutt-Fletcher et al.

Epstein-Barr virus (EBV) is a persistent, orally transmitted herpesvirus that replicates in B cells and epithelial cells and is associated...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances